finnCap is pleased to announce it has acted as buy-side adviser to Baird Capital on a growth capital investment from its Global Private Equity team, into Freemarket. The investment supports Freemarket’s continuing fast growth and international expansion, as well as providing a partial cash-out to existing shareholders.

Founded in 2011, Freemarket provides its customers with reliable and efficient B2B cross-border payments through its proprietary technology platform.  Freemarket’s global banking network and innovative technology platform enables customers to send payments/funds efficiently to over 100 countries in 140 currencies, removing cross-border payments complexities, improving transparency and increasing efficiency.

This deal underscores finnCap’s experience in the payments and fintech sector and was delivered by a multi-product team covering private markets M&A and public markets insight.

Ben Goldring, Head of Financial Services at finnCap, commented:

“We are delighted to have supported Baird Capital on this transaction, which will provide Freemarket with the ability to accelerate its growth trajectory. The regulated cross-border payments vertical is fast-growing and I expect there to be continued investment in the sector. I look forward to seeing Freemarket’s continued success in partnership with Baird Capital.”

finnCap Capital Markets acted as nominated adviser and broker in connection with Fadel Partners, Inc.’s AIM IPO. The Company raised £8m in order to execute on its next phase of growth.

Fadel is a leading developer of cloud-based brand compliance and rights and royalty management software, working with some of the world's leading licensors and licensees across media, entertainment, publishing, consumer brands and hi-tech/gaming companies.

finnCap Capital Markets has successfully raised £6 million for Ocean Harvest Technology's AIM IPO, with shares admitted to trading on AIM earlier today.

As one of the leading producers of seaweed blend ingredients for the animal feed market, Ocean Harvest Technology's unique products provide significant benefits to animal gut health, mortality, yield and sustainability.

The net proceeds of the Placing will be used by the Group to conduct effective marketing and grow further the Company’s global sales team, build out further the Company’s supply chain, including additional manufacturing capacity, conduct further R&D to continue to innovate and develop its products, expand production capacity at the Group’s facility in Vietnam, and provide general working capital. It will also provide access to capital should additional financing be required in the future to further expand the business.